Skip to content

Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes

Investigation Of Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes: A Cross-Sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07749222
Enrollment
24
Registered
2026-08-06
Start date
2024-12-01
Completion date
2025-06-30
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balance, Pulmonary Function, Quality of Life

Brief summary

Paralympic athletes actively participate in many sports despite their physical limitations and continue to develop both individually and athletically. Assessing the physical and functional capacities of these athletes is important in terms of performance and health. This study aimed to examine the relationships between respiratory function, respiratory muscle strength, lung age, balance, and quality of life in Paralympic athletes. Additionally, it was evaluated whether there were significant differences in these parameters according to disability type and gender. The study included 24 Paralympic athletes from the disciplines of athletics, swimming, archery, and wheelchair basketball. Participants had various orthopeadic and neurological disability types, including cerebral palsy, lower extremity amputation, spinal cord injuries (C5-T6 and T7 and below), hypotonia, poliomyelitis, spina bifida, brachial plexus injury, and short stature. Respiratory function was assessed using forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), FEV₁/FVC ratio, peak expiratory flow (PEF), and forced expiratory flow (FEF25-75%); respiratory muscle strength was assessed using maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP). Lung age was calculated based on FEV₁ values, balance was measured using the Modified Functional Reach Test, and quality of life was determined using the Short Form (SF-36) questionnaire. Significant correlations were found between parameters. Based on the study results, supporting respiratory muscle strength in Paralympic athletes may be an important goal in rehabilitation and training programs to support respiratory function, lung age, and quality of life parameters.

Interventions

None listed

Sponsors

Halic University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Being between 18-50 years of age * Being registered with any of the sports federations in Turkey and being a licensed paralympic athlete for at least 1 year ( * Having a lower extremity or upper extremity amputation or having permanent injuries as determined by the International Paralympic Committee

Exclusion criteria

* Lack of consent to participate in the study. * Having undergone surgery within the last 6 months. * Having had a respiratory tract infection within the three weeks prior to the evaluations * FEV1/FVC \< 0.7

Design outcomes

Primary

MeasureTime frameDescription
Forced expiratory volume in the first second (FEV1) (L)4 monthsPulmonary function (Forced expiratory volume in the first second FEV1)) was evaluated with a portable spirometer, COSMED Pony FX® (COSMED S.r.l., Italy) and measurements were performed according to European Respiratory Society standards. Considering that dizziness may occur during forced expiration, measurements were made while individuals were in a sitting position. While participants were sitting in a comfortable position in a chair with a backrest, nose clip was attached and they were asked to bite the mouth teeth and close their lips in a way that did not allow air to escape. The tests were performed at least 3 times by the participants and care was taken to ensure that the expiration time was at least 6 seconds and the plateau time was 1 second. Due to the device software that records all three data, it saved the average of the two best data and processed it as a value.

Secondary

MeasureTime frameDescription
Forced vital capacity (FVC) (L)4 monthsPulmonary function ((Forced vital capacity (FVC )) was evaluated with a portable spirometer.
FEV1 / FVC (%)4 monthsPulmonary function (FEV1 / FVC) was evaluated with a spirometer.
Peak flow rate (PEF) (L/s)4 monthsPulmonary function (Peak flow rate (PEF)) was evaluated with a spirometer.
Flow rate 25-75% of forced expiratory volume (FEF 25-75%) (L/s)4 monthsPulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) was evaluated with a spirometer.
Maximal expiratory pressure (MEP) (L)4 monthsThe MEP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
Maximal inspiratory pressure (MIP) (L)4 monthsThe MIP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
Balance4 monthsBalance was measured using the Modified Functional Reach Test
Quality of Life4 monthsQuality of life was determined using the Short Form-36 (SF-36) Health Survey that contains 36 questions and produces scores for eight health related quality of life domains. Each domain is transformed to a 0-100 scale. Higher scores represents better health status while lower stores represents poor health status.
Lung Age4 monthsLung age was calculated based on FEV₁ values. For male: Lung age (years)=(2.87×height in cm×0.394)-(31.25×FEV1 in L)-39.375 For females: Lung age (years)=(3.56×height in cm×0.394)-(40×FEV1 in L)-77.280

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026